Although SGLT2is have shown interesting benefits in terms of cardiac function with or without T2D, the expression of SGLT2 channels is negligible in the heart, further highlighting SGLT2-independent functions of these inhibitors in diabetic cardiomyopathy and cardiac dysfunction [134,135]. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.